Developer docs
API playgroundTry for free, no card

Search company profiles

Mawi

Full company profile

uuid0009hn8

Namestring
Mawi
Legal namestring
Mawi Inc.
Websiteurl
mawiheart.com
Company typeenum
Private
Founded yearint
2017
Descriptiontext

Mawi is a US-based digital health company founded in 2017 that develops a single-use, disposable wearable cardiac monitoring patch for healthcare providers and patients. The patch captures 2-channel ECG data via an X-shaped multiple vector electrode configuration and applies proprietary AI algorithms to perform continuous beat-to-beat analysis, detecting cardiac rhythm abnormalities in real time. The product supports Extended Holter monitoring (up to 7 days; up to 5 days in the US) and Event monitoring today, with Mobile Cardiac Telemetry (MCT) for high-risk patients (up to 30 days of real-time monitoring) listed as 'available soon.' A digital reporting platform delivers technician-validated reports to providers within 24 hours.

The company sells primarily to healthcare providers — cardiologists, electrophysiologists, and other clinicians — via a direct enterprise field sales motion, with role-segmented onboarding (Cardiology/EP, general clinicians, health plan representatives, healthcare executives, technicians). A secondary direct-to-patient telehealth channel enables home self-application, positioning Mawi as a B2B2C device-plus-service offering. Pricing is not publicly disclosed and is handled through quote-based engagement. Revenue mechanics are hardware sales of disposable patches bundled with technician-validated reporting services, billed pay-as-you-go. The company is privately held, incorporated in Delaware (headquartered at 919 North Market Street, Suite 950, Wilmington, DE 19801), operates only in the United States, and has 11-50 employees. Co-founders Ron Fridman (CEO), Andrew Klymenko (President & Chairman), Vitalii Sahan (VP of Engineering), and Artem Malynovskyi (CTO) lead the organization.

Short descriptiontext

Mawi is a US digital health company founded in 2017 that develops a single-use, disposable wearable cardiac monitoring patch with AI-powered beat-to-beat rhythm analysis, sold to cardiologists, electrophysiologists, and other healthcare providers through enterprise and direct-to-patient telehealth channels.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersClearwater, United States
HQ citystring
Clearwater
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cardiac monitoring devices, wearable ECG patch, holter monitoring, cardiac telemetry, remote patient monitoring
Industry2 codes
PRIMARYHLAFAKAE
Cardiac Diagnostic Centers (Echo/Stress Testing/Holter)
SECONDARYHLALAGAB
Cardiology Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)
NAICS code1 code
  • Offices of Physicians6211
SIC code1 code
  • Services-Offices & Clinics Of Doctors Of Medicine8011
Product category
Cardiac Monitoring Devices
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Cardiac Monitoring Devices and Services
TypeHardware Sales
Description

Mawi generates revenue through the sale of disposable cardiac monitoring patches to healthcare providers and health systems. The monitoring covers extended Holter (up to 7 days, up to 5 days in US), Event monitoring, and Mobile Cardiac Telemetry (MCT) for real-time monitoring up to 30 days. Reports are delivered through a digital platform with certified technician validation.

mawiheart.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales
Pricing details2 tiers
1Extended Holter Monitoring - Low-risk patients
ModelOtherBilling cadencePay-as-you-go
Notes

Up to 7 days monitoring (up to 5 days in US). Disposable single-use patch.

mawiheart.com
2Mobile Cardiac Telemetry (MCT) - High-risk patients
ModelOtherBilling cadencePay-as-you-go
Notes

Real-time monitoring up to 30 days. Available soon.

mawiheart.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Mawi designs and sells a single-use, disposable wearable cardiac monitoring patch that captures 2-channel ECG data and uses AI for continuous beat-to-beat rhythm analysis. The offering supports Extended Holter (up to 5-7 days), Event, and Mobile Cardiac Telemetry (up to 30 days) modes, with technician-validated reports delivered through a digital platform within 24 hours. Distribution is B2B to healthcare providers, with a telehealth option that ships the patch directly to patients for self-application at home.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Reports delivered within 24 hours, validated by certified technicians
Product overview1 text field

Mawi offers a unified cardiac monitoring ecosystem built around a single-use, disposable wearable patch device. The core Mawi Cardiac Monitoring system integrates hardware (wearable ECG patch with 2-channel detection), AI-powered software analysis (beat-to-beat rhythm abnormality detection), and a digital reporting platform. The offering includes multiple monitoring modes: Extended Holter for low-risk patients (up to 5-7 days) and Mobile Cardiac Telemetry for high-risk patients (real-time, up to 30 days). Reports are delivered via a digital platform within 24 hours, validated by certified technicians, and the device supports direct-to-patient telehealth with home self-application.

Product and service4 records
1Mawi Cardiac Monitoring
CategoryCardiac monitoring hardware
Description

A wearable cardiac monitoring system consisting of a single-use, fully disposable patch with integrated sensors that captures 2-channel ECG data and uses AI for continuous beat-to-beat analysis to detect cardiac rhythm abnormalities. Sold to healthcare providers for use by patients.

2Extended Holter Monitoring
CategoryCardiac monitoring service
Description

A monitoring configuration of the Mawi patch for low-risk patients, providing continuous cardiac monitoring for up to 7 days (up to 5 days in the US) and capturing ECG data for detailed post-hoc analysis.

3Mobile Cardiac Telemetry (MCT)
CategoryCardiac monitoring service
Description

A real-time monitoring configuration of the Mawi patch for high-risk patients, providing continuous cardiac telemetry for up to 30 days with AI-powered beat-to-beat analysis and technician-validated reports delivered within 24 hours.

4Mawi Digital Platform
CategoryCardiac monitoring software platform
Description

A digital platform for healthcare providers to access cardiac monitoring reports that are validated by certified technicians and delivered within 24 hours. Enables telehealth capabilities through direct-to-patient shipping and home self-application of the patch.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Medtronic's LINQ family of insertable cardiac monitors (ICMs) and broader cardiac diagnostics franchise competes for long-duration cardiac monitoring prescriptions, particularly in higher-acuity patients.

TypeEmerging player
Description

AliveCor offers KardiaMobile, a consumer and clinical ECG device (not patch-based) for arrhythmia detection. Competes for cardiology and primary care cardiac monitoring workflows with a different form factor but similar AI-ECG positioning.

TypeEmerging player
Description

Biotricity offers Bioflux, a remote cardiac monitoring solution including MCT functionality. Comparable RPM/cardiometabolic monitoring platform competing for similar cardiology and health system accounts.

TypeBroad incumbent
Description

GE Healthcare offers a portfolio of ambulatory ECG and cardiac telemetry solutions (e.g., MUSE, Holter systems). Broad incumbent in cardiac diagnostics with overlapping clinical customer base but different product mix.

TypeBroad incumbent
Description

Bardy's CAM patch was a notable patch-based cardiac monitor competing in the same extended Holter space. Acquired by Baxter, it represents a now-consolidated competitor in the disposable patch category.

TypeDirect peer
Description

iRhythm's Zio patch is the dominant single-use, long-duration cardiac monitoring patch in the US. Direct competitor offering similar disposable wearable ECG monitoring with AI-assisted analysis for arrhythmia detection.

TypeEmerging player
Description

HeartBeam develops a credit-card-sized 3D ECG device for at-home cardiac event detection. Focused on different form factor but similar telehealth-enabled cardiac diagnostic positioning targeting cardiology providers.

TypeBroad incumbent
Description

Acquired by Boston Scientific, Preventice offers BodyGuardian remote cardiac monitoring including MCT. Direct overlap in MCT and patch-based cardiac telemetry serving similar cardiology customers.

9VitalConnect
TypeEmerging player
Description

VitalConnect offers the VitalPatch wearable biosensor for continuous cardiac and multi-parameter monitoring in hospital and remote settings. Comparable wearable + AI monitoring approach with broader vital sign capture.

TypeBroad incumbent
Description

Philips acquired BioTel Heart to offer Mobile Cardiac Telemetry, Holter, and Event monitoring services. Overlapping product portfolio in cardiac ambulatory monitoring but as part of a broader health technology portfolio.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Mawi

Cardiac Monitoring Devicesmawiheart.com

Mawi is a US digital health company founded in 2017 that develops a single-use, disposable wearable cardiac monitoring patch with AI-powered beat-to-beat rhythm analysis, sold to cardiologists, electrophysiologists, and other healthcare providers through enterprise and direct-to-patient telehealth channels.

What Mawi does

Mawi is a US-based digital health company founded in 2017 that develops a single-use, disposable wearable cardiac monitoring patch for healthcare providers and patients. The patch captures 2-channel ECG data via an X-shaped multiple vector electrode configuration and applies proprietary AI algorithms to perform continuous beat-to-beat analysis, detecting cardiac rhythm abnormalities in real time. The product supports Extended Holter monitoring (up to 7 days; up to 5 days in the US) and Event monitoring today, with Mobile Cardiac Telemetry (MCT) for high-risk patients (up to 30 days of real-time monitoring) listed as 'available soon.' A digital reporting platform delivers technician-validated reports to providers within 24 hours.

The company sells primarily to healthcare providers — cardiologists, electrophysiologists, and other clinicians — via a direct enterprise field sales motion, with role-segmented onboarding (Cardiology/EP, general clinicians, health plan representatives, healthcare executives, technicians). A secondary direct-to-patient telehealth channel enables home self-application, positioning Mawi as a B2B2C device-plus-service offering. Pricing is not publicly disclosed and is handled through quote-based engagement. Revenue mechanics are hardware sales of disposable patches bundled with technician-validated reporting services, billed pay-as-you-go. The company is privately held, incorporated in Delaware (headquartered at 919 North Market Street, Suite 950, Wilmington, DE 19801), operates only in the United States, and has 11-50 employees. Co-founders Ron Fridman (CEO), Andrew Klymenko (President & Chairman), Vitalii Sahan (VP of Engineering), and Artem Malynovskyi (CTO) lead the organization.

Mawi firmographics

Firmographics
Name
Mawi
Legal name
Mawi Inc.
Website
https://mawiheart.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
11–50 employees
Short description
Mawi is a US digital health company founded in 2017 that develops a single-use, disposable wearable cardiac monitoring patch with AI-powered beat-to-beat rhythm analysis, sold to cardiologists, electrophysiologists, and other healthcare providers through enterprise and direct-to-patient telehealth channels.
Ownership category
akta.pro rank

Mawi industry classification

Industry
Product category
Cardiac Monitoring Devices
NAICS
Offices of Physicians (6211)
SIC
Services-Offices & Clinics Of Doctors Of Medicine (8011)
akta.pro industry
PRIMARYHLAFAKAE
Cardiac Diagnostic Centers (Echo/Stress Testing/Holter)
SECONDARYHLALAGAB
Cardiology Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)

Keywords

  • Cardiac monitoring devices
  • Wearable ECG patch
  • Holter monitoring
  • Cardiac telemetry
  • Remote patient monitoring

Where Mawi is headquartered

Location

Headquarters

HQ city
Clearwater
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Mawi business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales

Revenue model

  1. Cardiac Monitoring Devices and Services: Mawi generates revenue through the sale of disposable cardiac monitoring patches to healthcare providers and health systems. The monitoring covers extended Holter (up to 7 days, up to 5 days in US), Event monitoring, and Mobile Cardiac Telemetry (MCT) for real-time monitoring up to 30 days. Reports are delivered through a digital platform with certified technician validation.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goExtended Holter Monitoring - Low-risk patients
OtherPay-as-you-goMobile Cardiac Telemetry (MCT) - High-risk patients

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Mawi product offering

Product offering

Core offering

Mawi designs and sells a single-use, disposable wearable cardiac monitoring patch that captures 2-channel ECG data and uses AI for continuous beat-to-beat rhythm analysis. The offering supports Extended Holter (up to 5-7 days), Event, and Mobile Cardiac Telemetry (up to 30 days) modes, with technician-validated reports delivered through a digital platform within 24 hours. Distribution is B2B to healthcare providers, with a telehealth option that ships the patch directly to patients for self-application at home.

Product overview

Mawi offers a unified cardiac monitoring ecosystem built around a single-use, disposable wearable patch device. The core Mawi Cardiac Monitoring system integrates hardware (wearable ECG patch with 2-channel detection), AI-powered software analysis (beat-to-beat rhythm abnormality detection), and a digital reporting platform. The offering includes multiple monitoring modes: Extended Holter for low-risk patients (up to 5-7 days) and Mobile Cardiac Telemetry for high-risk patients (real-time, up to 30 days). Reports are delivered via a digital platform within 24 hours, validated by certified technicians, and the device supports direct-to-patient telehealth with home self-application.

Differentiator

Problem solved

Functional benefit

Products and services

  • Mawi Cardiac Monitoring A wearable cardiac monitoring system consisting of a single-use, fully disposable patch with integrated sensors that captures 2-channel ECG data and uses AI for continuous beat-to-beat analysis to detect cardiac rhythm abnormalities. Sold to healthcare providers for use by patients.
  • Extended Holter Monitoring A monitoring configuration of the Mawi patch for low-risk patients, providing continuous cardiac monitoring for up to 7 days (up to 5 days in the US) and capturing ECG data for detailed post-hoc analysis.
  • Mobile Cardiac Telemetry (MCT) A real-time monitoring configuration of the Mawi patch for high-risk patients, providing continuous cardiac telemetry for up to 30 days with AI-powered beat-to-beat analysis and technician-validated reports delivered within 24 hours.
  • Mawi Digital Platform A digital platform for healthcare providers to access cardiac monitoring reports that are validated by certified technicians and delivered within 24 hours. Enables telehealth capabilities through direct-to-patient shipping and home self-application of the patch.

Quantifiable outcome

  • Reports delivered within 24 hours, validated by certified technicians

Companies that use Mawi

Customer profile

Segments3 records

Ideal customer profiles2 records

Mawi technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature5 records

Mawi partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves4 records

Expansion highlights3 records

Mawi competitors and assessment

Company assessment

Broad incumbents

  • Medtronic: Medtronic's LINQ family of insertable cardiac monitors (ICMs) and broader cardiac diagnostics franchise competes for long-duration cardiac monitoring prescriptions, particularly in higher-acuity patients.
  • GE Healthcare: GE Healthcare offers a portfolio of ambulatory ECG and cardiac telemetry solutions (e.g., MUSE, Holter systems). Broad incumbent in cardiac diagnostics with overlapping clinical customer base but different product mix.
  • Bardy Diagnostics (now part of Baxter): Bardy's CAM patch was a notable patch-based cardiac monitor competing in the same extended Holter space. Acquired by Baxter, it represents a now-consolidated competitor in the disposable patch category.
  • Preventice Solutions (Boston Scientific): Acquired by Boston Scientific, Preventice offers BodyGuardian remote cardiac monitoring including MCT. Direct overlap in MCT and patch-based cardiac telemetry serving similar cardiology customers.
  • Philips (BioTel Heart): Philips acquired BioTel Heart to offer Mobile Cardiac Telemetry, Holter, and Event monitoring services. Overlapping product portfolio in cardiac ambulatory monitoring but as part of a broader health technology portfolio.

Emerging players

  • AliveCor: AliveCor offers KardiaMobile, a consumer and clinical ECG device (not patch-based) for arrhythmia detection. Competes for cardiology and primary care cardiac monitoring workflows with a different form factor but similar AI-ECG positioning.
  • Biotricity: Biotricity offers Bioflux, a remote cardiac monitoring solution including MCT functionality. Comparable RPM/cardiometabolic monitoring platform competing for similar cardiology and health system accounts.
  • HeartBeam: HeartBeam develops a credit-card-sized 3D ECG device for at-home cardiac event detection. Focused on different form factor but similar telehealth-enabled cardiac diagnostic positioning targeting cardiology providers.
  • VitalConnect: VitalConnect offers the VitalPatch wearable biosensor for continuous cardiac and multi-parameter monitoring in hospital and remote settings. Comparable wearable + AI monitoring approach with broader vital sign capture.

Direct peers

  • iRhythm Technologies: iRhythm's Zio patch is the dominant single-use, long-duration cardiac monitoring patch in the US. Direct competitor offering similar disposable wearable ECG monitoring with AI-assisted analysis for arrhythmia detection.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights7 records

Customer concentration

Mawi social profiles

Digital presence

Mawi financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Mawi leadership team

Management profile

Number of profiles

Profiles4 records

Mawi funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Mawi M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mawi

What does Mawi do?

Mawi designs and sells a single-use, disposable wearable cardiac monitoring patch that captures 2-channel ECG data and uses AI for continuous beat-to-beat rhythm analysis. The offering supports Extended Holter (up to 5-7 days), Event, and Mobile Cardiac Telemetry (up to 30 days) modes, with technician-validated reports delivered through a digital platform within 24 hours. Distribution is B2B to healthcare providers, with a telehealth option that ships the patch directly to patients for self-application at home.

Is Mawi a public or private company?

Mawi is a private company. It is classified as unknown and is currently operating.

When was Mawi founded?

Mawi was founded in 2017. It employs 11 to 50 people.

Where is Mawi based?

Mawi is headquartered in Clearwater, United States, in the North America region.

How does Mawi make money?

One revenue line is on record: cardiac Monitoring Devices and Services.

Who are Mawi's main competitors?

Broad incumbents on record are Medtronic, GE Healthcare, Bardy Diagnostics (now part of Baxter), Preventice Solutions (Boston Scientific) and Philips (BioTel Heart). Emerging players are AliveCor, Biotricity, HeartBeam and VitalConnect. iRhythm Technologies is listed as a direct peer.

Does Mawi have an API?

No public API is recorded for Mawi.

What industry is Mawi in?

Mawi's product category is Cardiac Monitoring Devices. Its primary akta.pro industry code is HLAFAKAE, Cardiac Diagnostic Centers (Echo/Stress Testing/Holter), with a secondary code of HLALAGAB, Cardiology Telemedicine Platforms. Its NAICS code is 6211 and its SIC code is 8011.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals